Secondary Logo

Journal Logo

November 2017 - Volume 28 - Issue 10
pp: 1067-1173

Extended topoisomerase 1 inhibition through liposomal irinotecan results in improved efficacy over topotecan and irinotecan in models of small-cell lung cancer

Leonard, Shannon C.; Lee, Helen; Gaddy, Daniel F.; More

Anti-Cancer Drugs. 28(10):1086-1096, November 2017.

Early tumor shrinkage indicates a favorable response to bevacizumab-based first-line chemotherapy for metastatic colorectal cancer

Ito, Mamoru; Kusaba, Hitoshi; Mukaide, Satomi; More

Anti-Cancer Drugs. 28(10):1166-1173, November 2017.